Ekocorp

Ekocorp Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Ekocorp (EKOCORP.NL) as of Oct 22, 2026 is -13.42 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was -15.96 % — a change of -15.94% (higher).

Cash Conversion

-13.42 %

YoY

-15.94%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Ekocorp is 2020 -13.42 % . Cash Conversion Rate (OCF/Net Income) of Ekocorp was 2019 -15.96 % . It decreases by -15.94% higher compared to the previous year.

The Ekocorp Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2015
-448.74 NGN
Jan 1, 2016
138.53 NGN
Jan 1, 2017
-0.79 NGN
Jan 1, 2018
-20.97 NGN
Jan 1, 2019
-15.96 NGN
Jan 1, 2020
-13.42 NGN
The Ekocorp Cash Conversion history
YEARCash ConversionYoY
-13.42 %-15.94%
-15.96 %-23.87%
-20.97 %+2,559.08%
-0.79 %-100.57%
138.53 %-130.87%
-448.74 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ekocorp Stock analysis

What does Ekocorp do? Ekocorp PLC provides healthcare services through its segments including standalone facilities, capitation models, and strategic business units such as general outpatients, nursing, intensive care, medical, obstetrics and gynaecology, paediatrics, radiology, and surgery. The company offers specialized medical services like dietician, diabetic nurse educator, foot care specialist, and consultant ophthalmologist. Its consultant services encompass general surgery, orthopaedic surgery, grammatology, otorhinolaryngology, audiology, speech therapy, dental surgery, ophthalmology, radiology, physical medicine (Physiotherapy), endoscopy, anaesthesia, obstetrics and gynaecology, radiotherapy, and oncology. Ekocorp also provides immunological screening services including thyroid antibodies, thyroid adrenal anti-nuclear antibodies, and paediatric endocrinology. The firm targets patients seeking specialized medical care and preventive health services. Its services are delivered through its healthcare delivery model focused on standard medical care and anchor services. Ekocorp's strategic business units serve diverse patient needs across various medical specialties. The company's offerings include both outpatient and inpatient care through its structured segments. Ekocorp PLC's revenue streams come from medical service fees charged to patients and healthcare providers. The company generates income through its consultant services, specialized medical care, and immunological screening services. Its business model relies on delivering high-quality healthcare services across multiple specialties to a broad patient base. The firm's segments operate under a unified healthcare delivery framework that supports its service offerings. Ekocorp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ekocorp stock

Cash Conversion Rate (OCF/Net Income) of Ekocorp is -13.42 % in 2020.

Cash Conversion Rate (OCF/Net Income) of Ekocorp changed from -15.96 % to -13.42 %, representing a -15.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Ekocorp since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Ekocorp with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ekocorp

All Key Metrics — Ekocorp